When we monitored the caspase activity in differentiated neuroblastoma cells expressing the caspase-6 (VEID) sensor treated with staurosporine we observed that the FRET intensity first decreased in the cell body and only 5-10 min later decreased in the neurites (Figure 4A and Additional file 2, Movie). This evidence concerns the gene CASP6 and neuroblastoma.